PT - JOURNAL ARTICLE AU - Velasco, Nubia AU - Herrera, Andrea AU - Trujillo-Diaz, Johanna AU - Amaya, Ciro-Alberto AU - González-Uribe, Catalina AU - Hernandez, Estefania TI - Design of logistics Indicators for Monitoring the Covid-19 Vaccination Process in Colombia AID - 10.1101/2023.02.23.23286347 DP - 2023 Jan 01 TA - medRxiv PG - 2023.02.23.23286347 4099 - http://medrxiv.org/content/early/2023/02/23/2023.02.23.23286347.short 4100 - http://medrxiv.org/content/early/2023/02/23/2023.02.23.23286347.full AB - The vaccine supply chain (VSC) integrates all the activities from production to dispensing. It is characterized by its complexity and low responsiveness, highlighting the importance of defining key performance indicators (KPIs). The design science research methodology was used to develop 38 KPIs, which were grouped into humanitarian and technological dimensions. The former includes demographic, epidemiological, and vaccination indicators, while the latter is classified into five groups according to the echelons of the supply chain. Public and private health organizations and research groups validated the indicators. They were calculated and recorded daily to monitor the logistics progress of the National Vaccination Plan against covid-19 in Colombia. These tailored KPIs, made it possible to evaluate and compare the results of the execution and effectiveness of public policies, and to redefine the strategies, showing that the logistics point of view helps identify the impact of good practices and transfer them promptly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by A mixed-methods study on the design of AI and data science-based strategies to inform public health responses to COVID-19 in different local health ecosystems within Colombia (COLEV) project funded by the International Development Research Centre (IDRC) and the Swedish International Development Cooperation Agency (SIDA) [109582].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Universidad de los Andes (Acta: No.1394 – 2021).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data files will be available in the data repository of the Universidad de los Andes: https://papyrus-datos.co/dataverse/uniandes_grupo-de-investigacion_colev.